newsfilter
← Latest News
PR Newswire·

Mirati Therapeutics and Sarah Cannon Research Institute Announce Strategic, Community Site Focused Partnership to Increase Diversity in Oncology Clinical Studies

SAN DIEGO and NASHVILLE, Tenn., May 8, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ:MRTX), a commercial stage biotechnology company, and Sarah Cannon Research Institute (SCRI), one of the world's